SCHEMBL928340

SCHEMBL928340

O=C(O)CCCCC(=O)Oc1ccccc1Oc1ccccc1O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.46
MEN1 O00255 1/20 0.46
RECQL P46063 1/20 0.46
KMT2A Q03164 1/20 0.46
PTGS2 P35354 1/20 0.41
HDAC3 O15379 2/20 0.40
HDAC4 P56524 2/20 0.40
HDAC1 Q13547 2/20 0.40
HDAC7 Q8WUI4 2/20 0.40
HDAC2 Q92769 2/20 0.40
HDAC10 Q969S8 2/20 0.40
HDAC11 Q96DB2 2/20 0.40
HDAC8 Q9BY41 2/20 0.40
HDAC6 Q9UBN7 2/20 0.40
HDAC9 Q9UKV0 2/20 0.40
HDAC5 Q9UQL6 2/20 0.40
MAPT P10636 1/20 0.40
RXFP1 Q9HBX9 1/20 0.40
THRA P10827 1/20 0.40
THRB P10828 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL926703 0.98 KDM4E (0.44) KDM4EMEN1RECQLKMT2APTGS2
SCHEMBL927217 0.98 KDM4E (0.44) KDM4EMEN1RECQLKMT2APTGS2
SCHEMBL27705565 0.91 KMT2A (0.50) KDM4EMEN1RECQLKMT2APTGS2
SCHEMBL27686632 0.89 KDM4E (0.49) KDM4EMEN1RECQLKMT2APTGS2
SCHEMBL27686551 0.89 KDM4E (0.49) KDM4EMEN1RECQLKMT2APTGS2
SCHEMBL689958 0.84 KMT2A (0.51) KDM4EMEN1RECQLKMT2AMAPT
SCHEMBL688760 0.82 KMT2A (0.50) KDM4EMEN1RECQLKMT2AMAPT
SCHEMBL688230 0.82 KMT2A (0.50) KDM4EMEN1RECQLKMT2AMAPT
SCHEMBL27705570 0.80 GAA (0.47) KDM4EMEN1RECQLKMT2AMAPT
SCHEMBL28847868 0.80 LMNA (0.58) KDM4EMEN1RECQLKMT2APTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8222446-B2 Method for producing dihydroxybenzene derivative MITSUI CHEMICALS, INC. (JP) 2012-07-17 US disclosed
US-20110004013-A1 METHOD FOR PRODUCING DIHYDROXYBENZENE DERIVATIVE MITSUI CHEMICALS, INC. (JP) 2011-01-06 US disclosed
EP-2269976-A1 PROCESS FOR PRODUCING DIHYDROXYBENZENE DERIVATIVE Mitsui Chemicals, Inc. (JP) 2011-01-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110004013-A1 METHOD FOR PRODUCING DIHYDROXYBENZENE DERIVATIVE UBE2B, UBE2G2, TUBB2B KDM4E 2323/4885MEN1 4103/4885RECQL 667/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.